Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma

Tumor-induced osteomalacia is a rare acquired metabolic bone disorder characterized by isolated renal phosphate wasting due to abnormal tumor production of fibroblast growth factor 23. We report the case of a 59 year old woman referred to our department with a long history of progressive diffuse mus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrine
Autors principals: Slot-Steenks, Mathilde M. Bruins, Hamdy, Neveen A.T., van de Sande, Michiel A.J., Vriens, Dennis, Cleven, Arjen H.G., Appelman-Dijkstra, Natasha M.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2016
Matèries:
Clinical Management of Endocrine Diseases
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5107201/
https://ncbi.nlm.nih.gov/pubmed/27709474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-016-1092-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars